- Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. Praga, C., Bergh, J., Bliss, J., Bonneterre, J., Cesana, B., Coombes, R.C., Fargeot, P., Folin, A., Fumoleau, P., Giuliani, R., Kerbrat, P., Hery, M., Nilsson, J., Onida, F., Piccart, M., Shepherd, L., Therasse, P., Wils, J., Rogers, D. J. Clin. Oncol. (2005)